{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:03:43Z","timestamp":1793088223232,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","award":["CB21\/13\/00002"],"award-info":[{"award-number":["CB21\/13\/00002"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015756","name":"Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijantimicag.2026.107787","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:41:01Z","timestamp":1774021261000},"page":"107787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["ESBL-producing Escherichia coli bacteraemic urinary tract infections: Clinical and economic burden and antimicrobial stewardship opportunities in a retrospective cohort study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5987-068X","authenticated-orcid":false,"given":"Silvia","family":"G\u00f3mez-Zorrilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2784-6914","authenticated-orcid":false,"given":"Grethel","family":"Rodr\u00edguez-Cabal\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"L\u00f3pez Montesinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soukaina Sara","family":"Alanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Franquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Pascual-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4910-1497","authenticated-orcid":false,"given":"Jes\u00fas","family":"Alonso-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3697-2552","authenticated-orcid":false,"given":"Alicia","family":"Rodr\u00edguez-Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-2173","authenticated-orcid":false,"given":"Elena","family":"Sendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Siverio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Esteban-Cuc\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Ana","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Duran-Jord\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-9001","authenticated-orcid":false,"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-5459","authenticated-orcid":false,"given":"Juan P.","family":"Horcajada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107787_bib0001","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3389\/fmicb.2017.01566","article-title":"Uropathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic and nonantibiotic antimicrobial strategies","volume":"8","author":"Terlizzi","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0002","series-title":"2024 WHO bacterial priority pathogens list to guide research, development and strategies to combat antimicrobial resistance","year":"2024"},{"issue":"3","key":"10.1016\/j.ijantimicag.2026.107787_bib0003","doi-asserted-by":"crossref","first-page":"dlab092","DOI":"10.1093\/jacamr\/dlab092","article-title":"Extended-spectrum \u03b2lactamases: an update on their characteristics, epidemiology and detection","volume":"3","author":"Castanheira","year":"2021","journal-title":"JAC Antimicrob Resist"},{"issue":"8","key":"10.1016\/j.ijantimicag.2026.107787_bib0004","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/jac\/dkx146","article-title":"Global epidemiology of CTXM betalactamases: temporal and geographical shifts in genotype","volume":"72","author":"Bevan","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ijantimicag.2026.107787_bib0005","first-page":"906","article-title":"REIPI\/ESGBIS\/INCREMENT Group. Development and validation of the INCREMENTESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae","volume":"72","author":"PalaciosBaena","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.ijantimicag.2026.107787_bib0006","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"MERINO Trial investigators. Effect of piperacillin tazobactam vs meropenem on 30day mortality for patients with Escherichia coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ijantimicag.2026.107787_bib0007","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1128\/AAC.00143-10","article-title":"Costs of bloodstream infections caused by Escherichia coli and influence of extended spectrum \u03b2lactamase production and inadequate initial antibiotic therapy","volume":"54","author":"Tumbarello","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijantimicag.2026.107787_bib0008","doi-asserted-by":"crossref","first-page":"dlab068","DOI":"10.1093\/jacamr\/dlab068","article-title":"Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBLE): a systematic review and metaanalysis","volume":"3","author":"Ling","year":"2021","journal-title":"JAC Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107787_bib0009","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug resistant gram negative bacilli (endorsed by European Society of Intensive Care Medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0010","doi-asserted-by":"crossref","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial resistant gramnegative infections","volume":"7","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"9596","key":"10.1016\/j.ijantimicag.2026.107787_bib0011","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0012","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic in longitudinal studies: development","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107787_bib0013","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s40121-021-00537-0","article-title":"REIPI\/GEIRAS-GEMARA SEIMC ITUBRAS-2 Group. A large multicenter prospective study of community-onset healthcare-associated bacteraemic urinary tract infections in the era of multidrug resistance: even worse than hospital-acquired infections?","volume":"10","author":"G\u00f3mez-Zorrilla","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0014","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/SHK.0b013e318182f98f","article-title":"Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the PITT bacteraemia score and the acute physiology and chronic health evaluation II scoring systems","volume":"31","author":"Rhee","year":"2009","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.ijantimicag.2026.107787_bib0015","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/CCM.0b013e31819def97","article-title":"The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation","volume":"37","author":"Jones","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0016","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance 2026 [accessed 12.01.26]. https:\/\/www.eucast.org\/resistance_mechanisms\/"},{"issue":"6","key":"10.1016\/j.ijantimicag.2026.107787_bib0017","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","article-title":"Predictors of mortality in ESBL bloodstream infections","volume":"51","author":"Tumbarello","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2015.07.010","article-title":"Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study","volume":"39","author":"Denis","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"7","key":"10.1016\/j.ijantimicag.2026.107787_bib0019","doi-asserted-by":"crossref","first-page":"ofaf365","DOI":"10.1093\/ofid\/ofaf365","article-title":"Infection risk associated with colonization by multidrug-resistant gram-negative bacteria: an umbrella review and meta-analysis","volume":"12","author":"Wilbur Woodhouse","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0020","article-title":"Effects of inappropriate administration of empirical antibiotics on mortality in adults with bacteraemia: systematic review and meta-analysis","volume":"9","author":"Hung","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0021","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40560-019-0383-3","article-title":"JAAM FORECAST group. Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan","volume":"7","author":"Abe","year":"2019","journal-title":"J Intensive Care"},{"issue":"12","key":"10.1016\/j.ijantimicag.2026.107787_bib0022","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1093\/jac\/dkaa361","article-title":"Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark","volume":"75","author":"Richelsen","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.ijantimicag.2026.107787_bib0023","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteremia due to extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli in the CTX-M era: a new clinical challenge","volume":"43","author":"Rodr\u00edguez-Ba\u00f1o","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107787_bib0024","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1186\/s13104-019-4751-9","article-title":"Mortality risk of bloodstream infection caused by either Escherichia coli or Klebsiella pneumoniae producing extended-spectrum \u03b2-lactamase: a prospective cohort study","volume":"12","author":"Sianipar","year":"2019","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijid.2023.11.007","article-title":"Mortality, hospital length of stay, and recurrent bloodstream infections associated with extended-spectrum beta-lactamase-producing Escherichia coli in a low prevalence region: A 20-year population-based large cohort study","volume":"138","author":"Ling","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2026.107787_bib0026","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/23744235.2023.2261538","article-title":"Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli","volume":"56","author":"Handal","year":"2024","journal-title":"Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0027","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/RMHP.S453686","article-title":"Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors and economic burden among patients with bloodstream infections","volume":"17","author":"Chen","year":"2024","journal-title":"Risk Manag Healthc Policy"},{"issue":"6","key":"10.1016\/j.ijantimicag.2026.107787_bib0028","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jinf.2015.08.012","article-title":"Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study","volume":"71","author":"Esteve-Palau","year":"2015","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.ijantimicag.2026.107787_bib0029","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/jac\/dkad402","article-title":"Swedish ESBL study group. Treatment, outcomes and characterization of pathogens in urinary tract infections caused by ESBL-producing enterobacterales: a prospective multicentre study","volume":"79","author":"Montelin","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0030","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.1038\/s41598-022-14177-y","article-title":"The impact of the ST131 clone on recurrent ESBL-producing E. coli urinary tract infection: a prospective comparative study","volume":"12","author":"Lindblom","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ijantimicag.2026.107787_bib0031","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/jac\/dkad234","article-title":"Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)","volume":"78","author":"Becerra-Aparicio","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0032","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.2147\/IDR.S271230","article-title":"Economic burden of patients with bloodstream infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"13","author":"Wang","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107787_bib0033","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jhm.2157","article-title":"Impact of extended-spectrum \u03b2-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection","volume":"9","author":"MacVane","year":"2014","journal-title":"J Hosp Med"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0034","doi-asserted-by":"crossref","DOI":"10.2196\/53828","article-title":"Economic burden of community-acquired antibiotic-resistant urinary tract infections: systematic review and meta-analysis","volume":"10","author":"Zhu","year":"2024","journal-title":"JMIR Public Health Surveill"},{"issue":"4","key":"10.1016\/j.ijantimicag.2026.107787_bib0035","doi-asserted-by":"crossref","first-page":"ofae193","DOI":"10.1093\/ofid\/ofae193","article-title":"Real-world effectiveness of intravenous and oral antibiotic stepdown strategies for gram-negative complicated urinary tract infection with bacteremia","volume":"11","author":"Veillette","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.ijantimicag.2026.107787_bib0036","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/jac\/dkad147","article-title":"Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial","volume":"78","author":"Sojo-Dorado","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107787_bib0037","doi-asserted-by":"crossref","first-page":"1093842","DOI":"10.3389\/fcimb.2023.1093842","article-title":"Efficacy and safety of piperacillin-tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.ijantimicag.2026.107787_bib0038","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijantimicag.2018.07.021","article-title":"BL\/BLI versus carbapenems for ESBL bacteraemia: meta-analysis","volume":"52","author":"Sfeir","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.ijantimicag.2026.107787_bib0039","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1017\/ice.2015.101","article-title":"Carbapenems versus piperacillin-tazobactam for non-urinary ESBL bacteraemia","volume":"36","author":"Ofer-Friedman","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"10.1016\/j.ijantimicag.2026.107787_bib0040","doi-asserted-by":"crossref","first-page":"ofab387","DOI":"10.1093\/ofid\/ofab387","volume":"8","author":"Stewart","year":"2021","journal-title":"Open Forum Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T19:04:05Z","timestamp":1779735845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0924857926000762"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107787","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESBL-producing Escherichia coli bacteraemic urinary tract infections: Clinical and economic burden and antimicrobial stewardship opportunities in a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107787"}}